FIELD: medicine.
SUBSTANCE: invention can be used for treating patients with locally advanced cervical cancer. Method involves with underlying systemic polychemotherapy, daily for 7 days, local sonodynamic chemotherapy using mid-frequency ultrasonic exposure, exposure time of 15 minutes. Cytostatic used is 5 % 5-fluorouracil gel 20 mg, which is applied on sounding waveguide surface and easily moving it in lesion, not separated from surface, ultrasonic effect on tumour; therapeutic course is repeated every 21 days.
EFFECT: using invention improves effects of preoperative treatment.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PATIENTS SUFFERING LOCALLY ADVANCED CERVICAL CANCER | 2014 |
|
RU2547569C1 |
| METHOD OF NEOADJUVANT TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2017 |
|
RU2648642C1 |
| METHOD FOR PREVENTION OF HAEMATOGENOUS METASTASIS IN SURGICAL TREATMENT OF PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2015 |
|
RU2591612C1 |
| METHOD OF THE TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER OF IB3-IIIB STAGES | 2022 |
|
RU2799247C2 |
| METHOD FOR MULTIMODALITY TREATMENT OF LOCALLY ADVANCED CERVICAL CARCINOMA | 2008 |
|
RU2386460C2 |
| METHOD OF TREATING CERVICAL CANCER USING CHEMOEMBOLISATION OF UTERINE ARTERIES WITH PLATINUM DRUGS | 2015 |
|
RU2583144C1 |
| METHOD FOR TREATMENT OF PRIMARY PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2015 |
|
RU2616531C1 |
| METHOD FOR TREATMENT OF ANAL CANCER WITH SKIN TRANSITION | 2016 |
|
RU2638616C1 |
| METHOD FOR COMBINED TREATMENT OF LOCALLY ADVANCED FORMS OF CERVICAL CANCER IIB-IIIB (T2B-T3BN0(1)M0) STAGES | 2020 |
|
RU2748135C2 |
| METHOD OF COMBINATION THERAPY APPLIED FOR LOCALLY ADVANCED CERVICAL CARCINOMA TYPES | 2006 |
|
RU2325199C2 |
